02:23 , Apr 16, 2015 |  BC Extra  |  Company News

Management tracks

Merck KGaA (Xetra:MRK) said Udit Batra will become head of its combined life sciences business, pending completion in mid-2015 of its planned acquisition of Sigma-Aldrich Corp. (NASDAQ:SIAL). Batra has been CEO and president of Merck...
07:00 , Jun 9, 2014 |  BC Week In Review  |  Company News

Strand Life Sciences Pvt. Ltd., HealthCare Global Enterprises Ltd. deal

Strand partnered with HealthCare Global Enterprises (HCG) to provide personalized genomics services for oncology to hospitals and diagnostic labs worldwide on a fee-for-service basis. Strand said the partnership will use Strand's StrandOmics technology and its...
07:00 , Apr 1, 2013 |  BC Week In Review  |  Company News

Trovagene sales and marketing update

Trovagene launched its HPV-HR assay in the U.S. to detect HPV. The assay detects DNA sequences of 15 high-risk HPV strains from urine specimens. The test is conducted at Trovagene's CLIA-certified and CAP-accredited lab. Last...
08:00 , Feb 18, 2013 |  BC Week In Review  |  Financial News

Strand Life Sciences completes venture financing

Strand Life Sciences Pvt. Ltd. , Bangalore, India   Business: Bioinformatics   Date completed: 2/11/13   Type: Venture financing   Raised: $10 million   Investor: Burrill & Co.  ...
07:00 , Oct 1, 2012 |  BC Week In Review  |  Company News

Strand Life Sciences, Trovagene deal

Trovagene and Strand Life Sciences partnered to validate and commercialize Trovagene's urine-based HPV screening test and high risk HPV DNA Assay in India and South Asia. The parties signed a memorandum of understanding in June....
07:00 , Jun 11, 2012 |  BC Week In Review  |  Company News

Strand Life Sciences, Trovagene deal

The companies signed a memorandum of understanding to validate Trovagene's HPV assay technology and grant Strand rights to use the tests in India and South Asia. Strand said it will establish Trovagene's urine-based HPV screening...
08:00 , Feb 27, 2006 |  BC Week In Review  |  Company News

Pharmidex Pharmaceutical Services Ltd., Strand Life Sciences Pvt. Ltd. deal

The companies partnered to develop software that predicts the ability of compounds to cross the blood-brain barrier. The deal combines Strand's in silico technologies with Pharmidex's services, which include running in vitro and ex vivo...
08:00 , Dec 12, 2005 |  BC Week In Review  |  Company News

Strand Life Sciences Pvt. Ltd., Stratagene deal

The companies partnered to develop a suite of bioinformatics software tools for systems biology-focused pathway analysis. STGN will exclusively market resulting products, which will use Strand's avadis software for analyzing gene expression data. Strand Life...
07:00 , Oct 3, 2005 |  BC Week In Review  |  Company News

Elan, Strand Life Sciences Pvt. Ltd. deal

ELN received access to Strand's in silico technology, including predictive modeling for efficacy and ADMET, custom library design, pharmacophore modeling and structure-based drug design. Elan Corp. plc (ELN), Dublin, Ireland   Strand Life Sciences Pvt....
07:00 , Sep 27, 2004 |  BC Week In Review  |  Company News

Strand, MediBic deal

MediBic took a minority equity stake in partner Strand. The companies have a deal to develop and market informatics products in Japan. Strand Genomics Pvt. Ltd. , Bangalore, India   MediBic , Tokyo, Japan  ...